Ethical dilemmas in COVID-19 patients awaiting lung transplantation on extracorporeal membrane oxygenation

Author:

Trejnowska Ewa1,Urlik Maciej1,Ochman Marek1,Wajda-Pokrontka Marta1,Cyprys Paweł1,Przybyłowski Piotr1,Skoczyński Szymon1,Knapik Piotr1

Affiliation:

1. Medical University of Silesia in Katowice

Abstract

Abstract Background: Extracorporeal membrane oxygenation (ECMO) may serve as a bridge to successful lung transplantation (LT) in selected patients with coronavirus disease 19 (COVID- 19) pneumonia. Compliance with the recognized LT criteria however, may be impossible to be met in this particular and extremely challenging group of patients. This situation create huge moral and ethical dilemmas. To indicate this, we decided to explore this difficult topic and present how non-compliance to the recognized LT criteria enabled us to perform three successful and life-saving LT procedures in COVID-19 patients. Methods: Data of all consecutive patients on ECMO support as rescue treatment for COVID- 19 pneumonia, awaiting LT at SCHD between October 1, 2020 and May 31, 2021 were reviewed. Results: 18 patients on ECMO entered the list for LT at SCHD (mean age: 40.5 ± 5.6 years, range 28–48 years). Mean duration of ECMO was 29.6 ± 15.5 days (range 6–71 days). 11 patients died: either during LT (n = 3), post-LT (n = 1), or on ECMO awaiting LT (n = 7). The overall mortality rate in this group was 61.1%. Survivors (n=7) were either successfully transplanted (n = 3) or weaned from ECMO (n = 4). In the medical literature, there are several enthusiastic case reports describing successful LTs, however there might be a significant publication bias in this area, as failed procedures probably remain largely under-reported. There are no data to indicate the right time for LT in post-COVID-19 patients. Experts in this field require minimum recovery period of 4 weeks to exclude native lung recovery, active participation in physical rehabilitation and the possibility of providing informed consent to proceed with LT. All these conditions were impossible to be met in our patients awaiting LT on ECMO support. Conclusions: Traditional lung transplantation criteria are difficult to be applied in COVID-19 patients requiring ECMO support due to medical and ethical reasons. Performing LT without prior consent of patients violates the ethical principles of solid organ transplants, but may be life-saving in some patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3